We live in the Age of Mobile phone motion
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
currently considering several development projects.
For further information on the Company, please contact Joseph Byrne, Chief Executive Officer and a Director at phone: 519-257-0460 or by email at: joe@emergenceglobalinc.com.
Cautionary Statement Regarding Forward-Looking Information
Forward-Looking Statements
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to closing and the terms and conditions of the proposed transaction; the business and operations of the Company after closing the proposed transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties; delay or failure to receive board, shareholder, or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. There can be no assurance that the proposed transaction will occur or that the anticipated financial, economic, or strategic benefits will be realized.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) nor OTC Markets accepts responsibility for the adequacy or accuracy of this press release.
Brian S. Payne
Emergence Global Enterprises Inc.
+1 519-981-0970
currently considering several development projects.
For further information on the Company, please contact Joseph Byrne, Chief Executive Officer and a Director at phone: 519-257-0460 or by email at: joe@emergenceglobalinc.com.
Cautionary Statement Regarding Forward-Looking Information
Forward-Looking Statements
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to closing and the terms and conditions of the proposed transaction; the business and operations of the Company after closing the proposed transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties; delay or failure to receive board, shareholder, or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. There can be no assurance that the proposed transaction will occur or that the anticipated financial, economic, or strategic benefits will be realized.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) nor OTC Markets accepts responsibility for the adequacy or accuracy of this press release.
Brian S. Payne
Emergence Global Enterprises Inc.
+1 519-981-0970
currently considering several development projects.
For further information on the Company, please contact Joseph Byrne, Chief Executive Officer and a Director at phone: 519-257-0460 or by email at: joe@emergenceglobalinc.com.
Cautionary Statement Regarding Forward-Looking Information
Forward-Looking Statements
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to closing and the terms and conditions of the proposed transaction; the business and operations of the Company after closing the proposed transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties; delay or failure to receive board, shareholder, or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. There can be no assurance that the proposed transaction will occur or that the anticipated financial, economic, or strategic benefits will be realized.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) nor OTC Markets accepts responsibility for the adequacy or accuracy of this press release.
Brian S. Payne
Emergence Global Enterprises Inc.
+1 519-981-0970
Poor Brian Poor Joe with friends of you behind them every step of the way.
You giving names for everyone to point the finger at when things go wrong.
The telephone numbers are in the links call the regulators and ask yourself.
The telephone numbers are in the links call the regulators and ask yourself.
The telephone numbers are in the links call the regulators and ask yourself.
They missed 3 filings halted
You can call don't be lazy
Emergence global halted he was one of the
Founding members and it was halted last week for a week so far.
Thomas Canning he was chief financial officer chapter 11
Companies he is part of usually go down in flames
Emergence Global Enterprises Inc. ("Emergence") is an acquirer, creator, and builder of reputable natural health consumer foods, products, and brands. Emergence has become a North American developer and distributor of branded natural health foods, supplements, and sports nutrition specialty supplements. The Company is currently considering several development projects.
For further information on the Company, please contact Joseph Byrne, Chief Executive Officer and a Director at phone: 519-257-0460 or by email at: joe@emergenceglobalinc.com.
Cautionary Statement Regarding Forward-Looking Information
Forward-Looking Statements
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to closing and the terms and conditions of the proposed transaction; the business and operations of the Company after closing the proposed transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties; delay or failure to receive board, shareholder, or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. There can be no assurance that the proposed transaction will occur or that the anticipated financial, economic, or strategic benefits will be realized.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) nor OTC Markets accepts responsibility for the adequacy or accuracy of this press release.
Brian S. Payne
Emergence Global Enterprises Inc.
+1 519-981-0970
email us here
Emergence Global Enterprises Inc. ("Emergence") is an acquirer, creator, and builder of reputable natural health consumer foods, products, and brands. Emergence has become a North American developer and distributor of branded natural health foods, supplements, and sports nutrition specialty supplements. The Company is currently considering several development projects.
For further information on the Company, please contact Joseph Byrne, Chief Executive Officer and a Director at phone: 519-257-0460 or by email at: joe@emergenceglobalinc.com.
Cautionary Statement Regarding Forward-Looking Information
Forward-Looking Statements
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to closing and the terms and conditions of the proposed transaction; the business and operations of the Company after closing the proposed transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties; delay or failure to receive board, shareholder, or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. There can be no assurance that the proposed transaction will occur or that the anticipated financial, economic, or strategic benefits will be realized.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) nor OTC Markets accepts responsibility for the adequacy or accuracy of this press release.
Brian S. Payne
Emergence Global Enterprises Inc.
+1 519-981-0970
email us here
Brian Payne and Emergence scroll to the bottom
Emergence Global Enterprises Inc. ("Emergence") is an acquirer, creator, and builder of reputable natural health consumer foods, products, and brands. Emergence has become a North American developer and distributor of branded natural health foods, supplements, and sports nutrition specialty supplements. The Company is currently considering several development projects.
For further information on the Company, please contact Joseph Byrne, Chief Executive Officer and a Director at phone: 519-257-0460 or by email at: joe@emergenceglobalinc.com.
Cautionary Statement Regarding Forward-Looking Information
Forward-Looking Statements
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to closing and the terms and conditions of the proposed transaction; the business and operations of the Company after closing the proposed transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties; delay or failure to receive board, shareholder, or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. There can be no assurance that the proposed transaction will occur or that the anticipated financial, economic, or strategic benefits will be realized.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) nor OTC Markets accepts responsibility for the adequacy or accuracy of this press release.
Brian S. Payne
Emergence Global Enterprises Inc.
+1 519-981-0970
email us here
This is second company besides Thomas Canning that Brian Payne has been associated with that has had accounting problems they need to do a deep dive into CEN Biotechs books..anyway emrg Brian's other company got halted by BC securities for missing multiple filings.
Leadership is clearly in weak hands.
Was it by design?.
Brian S. Payne
Emergence Global Enterprises Inc.
+1 519-981-0970
Looking to see if Brian Payne was ever involved with this company that got halted
For further information about IIROC's trading halt policy, please see Trading Halts & Timely Disclosure (https://www.iiroc.ca/news-and.../halts-and-resumptions) at www.iiroc.ca under the Halts and Resumptions tab. Please note that IIROC staff cannot provide any information about a specific halt beyond what is contained in this halt notice. For general information about IIROC, contact IIROC's Complaints and Inquiries team at inquiries@iiroc.ca or 1-877-442-4322 (Option 2). For company-related enquiries, contact the company directly.
For further information about IIROC's trading halt policy, please see Trading Halts & Timely Disclosure (https://www.iiroc.ca/news-and.../halts-and-resumptions) at www.iiroc.ca under the Halts and Resumptions tab. Please note that IIROC staff cannot provide any information about a specific halt beyond what is contained in this halt notice. For general information about IIROC, contact IIROC's Complaints and Inquiries team at inquiries@iiroc.ca or 1-877-442-4322 (Option 2). For company-related enquiries, contact the company directly.
For further information about IIROC's trading halt policy, please see Trading Halts & Timely Disclosure (https://www.iiroc.ca/news-and.../halts-and-resumptions) at www.iiroc.ca under the Halts and Resumptions tab. Please note that IIROC staff cannot provide any information about a specific halt beyond what is contained in this halt notice. For general information about IIROC, contact IIROC's Complaints and Inquiries team at inquiries@iiroc.ca or 1-877-442-4322 (Option 2). For company-related enquiries, contact the company directly.
Emrg/Eloaf halted
HALTED They missed 3 mandatory financial filings seems like the Bsbc regulators are putting a dent in the emrg/eloaf plans for vertical integration 3 filings these clowns miss
CEASE TRADED REPORTING ISSUERS LIST | BCSC
https://www.bcsc.bc.ca/industry/issuer-regulation/...
View a PDF of the BCSC Cease Traded Reporting Issuers List. Note: List below shows the company or person (s) that are currently cease traded or management cease traded; to view a complete listing select their name. Cease Traded Reporting Issuers List Updated as of 2023-03-07 12:00:00 AM Issuer Name Principal CTO MCTO View Results
https://www.bcsc.bc.ca/.../2023/2023-BCSECCOM-107.pdf...
.ca/-/media/PWS/New-Resources/Decision-and-Orders/Cease-Trade-Orders/2023/2023-BCSECCOM-107.pdf?dt=20230306225000
Emergence Global Enterprises Inc. (the Issuer) Under the securities legislation of British Columbia and Ontario (Legislation) Background ¶ 1 This is the order of the regulator of the British Columbia Securities Commission (the Principal Regulator) and evidences the decision of the regulator or securities regulatory authority in Ontario (each a Decision Maker). ¶ 2 The Issuer has not filed the following periodic disclosure required by the Legislation: 1. annual audited financial statements for the year ended October 31, 2022, 2. annual management’s discussion and analysis for the year ended October 31, 2022, 3. certification of annual filings for the year ended October 31, 2022. ¶ 3 As a result of this order, if the Issuer is a reporting issuer in a jurisdiction in which Multilateral Instrument 11-103 Failure-to-File Cease Trade Orders in Multiple Jurisdictions applies, a person or company must not trade in or purchase a security of the Issuer in that jurisdiction, except in accordance with the conditions that are contained in this order, if any, for so long as this order remains in effect. ¶ 4 Further, this order takes automatic effect in each jurisdiction of Canada that has a statutory reciprocal order provision, subject to the terms of the local securities legislation. Interpretation ¶ 5 Terms defined in the Legislation, National Instrument 14-101 Definitions and National Policy 11-207 Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions have the same meaning if used in this order, unless otherwise defined. Order ¶ 6 Each of the Decision Makers is satisfied that the decision concerning the cease trade meets the test set out in the Legislation to make this decision. ¶ 7 It is ordered under the Legislation that trading cease in respect of each security of the Issuer. ¶ 8 Despite this order, a beneficial securityholder of the Issuer who is not, and was not at the date of this order, an insider or control person of the Issuer, may sell securities of the Issuer acquired before the date of this order if both of the following apply: 1. the sale is made through a “foreign organized regulated market”, as defined in section 1.1 of the Universal Market Integrity Rules of the Investment Industry Regulatory Organization of Canada; and 2. the sale is made through an investment dealer registered in a jurisdiction of Canada in accordance with applicable securities legislation. ¶ 9 March 6, 2023 Michael Moretto Michael Moretto, CPA, CA, CPA (Illinois) Deputy Director, Corp
BCSC Logo
CEASE TRADE ORDERS
EMERGENCE GLOBAL ENTERPRISES INC. [CEASE TRADE ORDER]
BCSECCOM #:
2023 BCSECCOM 107
Document Type:
Cease Trade Order
Published Date:
2023-03-06
Effective Date:
2023-03-06
Details:
2023 BCSECCOM 107 ??
Click on the Adobe icon to launch the Acrobat Reader
https://www.bcsc.bc.ca/.../2023/2023-BCSECCOM-107.pdf...
BCSC Logo
CEASE TRADE ORDERS
EMERGENCE GLOBAL ENTERPRISES INC. [CEASE TRADE ORDER]
BCSECCOM #:
2023 BCSECCOM 107
Document Type:
Cease Trade Order
Published Date:
2023-03-06
Effective Date:
2023-03-06
Details:
2023 BCSECCOM 107
HALTED They missed 3 mandatory financial filings seems like the Bsbc regulators are putting a dent in the emrg/eloaf plans for vertical integration 3 filings these clowns miss
CEASE TRADED REPORTING ISSUERS LIST | BCSC
https://www.bcsc.bc.ca/industry/issuer-regulation/...
View a PDF of the BCSC Cease Traded Reporting Issuers List. Note: List below shows the company or person (s) that are currently cease traded or management cease traded; to view a complete listing select their name. Cease Traded Reporting Issuers List Updated as of 2023-03-07 12:00:00 AM Issuer Name Principal CTO MCTO View Results
https://www.bcsc.bc.ca/.../2023/2023-BCSECCOM-107.pdf...
.ca/-/media/PWS/New-Resources/Decision-and-Orders/Cease-Trade-Orders/2023/2023-BCSECCOM-107.pdf?dt=20230306225000
Emergence Global Enterprises Inc. (the Issuer) Under the securities legislation of British Columbia and Ontario (Legislation) Background ¶ 1 This is the order of the regulator of the British Columbia Securities Commission (the Principal Regulator) and evidences the decision of the regulator or securities regulatory authority in Ontario (each a Decision Maker). ¶ 2 The Issuer has not filed the following periodic disclosure required by the Legislation: 1. annual audited financial statements for the year ended October 31, 2022, 2. annual management’s discussion and analysis for the year ended October 31, 2022, 3. certification of annual filings for the year ended October 31, 2022. ¶ 3 As a result of this order, if the Issuer is a reporting issuer in a jurisdiction in which Multilateral Instrument 11-103 Failure-to-File Cease Trade Orders in Multiple Jurisdictions applies, a person or company must not trade in or purchase a security of the Issuer in that jurisdiction, except in accordance with the conditions that are contained in this order, if any, for so long as this order remains in effect. ¶ 4 Further, this order takes automatic effect in each jurisdiction of Canada that has a statutory reciprocal order provision, subject to the terms of the local securities legislation. Interpretation ¶ 5 Terms defined in the Legislation, National Instrument 14-101 Definitions and National Policy 11-207 Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions have the same meaning if used in this order, unless otherwise defined. Order ¶ 6 Each of the Decision Makers is satisfied that the decision concerning the cease trade meets the test set out in the Legislation to make this decision. ¶ 7 It is ordered under the Legislation that trading cease in respect of each security of the Issuer. ¶ 8 Despite this order, a beneficial securityholder of the Issuer who is not, and was not at the date of this order, an insider or control person of the Issuer, may sell securities of the Issuer acquired before the date of this order if both of the following apply: 1. the sale is made through a “foreign organized regulated market”, as defined in section 1.1 of the Universal Market Integrity Rules of the Investment Industry Regulatory Organization of Canada; and 2. the sale is made through an investment dealer registered in a jurisdiction of Canada in accordance with applicable securities legislation. ¶ 9 March 6, 2023 Michael Moretto Michael Moretto, CPA, CA, CPA (Illinois) Deputy Director, Corp
BCSC Logo
CEASE TRADE ORDERS
EMERGENCE GLOBAL ENTERPRISES INC. [CEASE TRADE ORDER]
BCSECCOM #:
2023 BCSECCOM 107
Document Type:
Cease Trade Order
Published Date:
2023-03-06
Effective Date:
2023-03-06
Details:
2023 BCSECCOM 107 ??
Click on the Adobe icon to launch the Acrobat Reader
https://www.bcsc.bc.ca/.../2023/2023-BCSECCOM-107.pdf...
BCSC Logo
CEASE TRADE ORDERS
EMERGENCE GLOBAL ENTERPRISES INC. [CEASE TRADE ORDER]
BCSECCOM #:
2023 BCSECCOM 107
Document Type:
Cease Trade Order
Published Date:
2023-03-06
Effective Date:
2023-03-06
Details:
2023 BCSECCOM 107
Ok they were halted they ran this company and Fitx before you sound like you know everything the way you come off.
Why did Chaabans other stock emrg/Eloaf get halted the other day. It has the same people that were involved with CEN Biotech
And you invested in a Chaaban stock. All he does is cry victim about something that happened to him in the past.
Why did emrg get halted?
Why did emergence get halted?
Fitx this stock Cenbf and Eloaf are all the same people. Google and Bing is a wonderful thing just cross reference their names and you will see why they don't deserve your money or anyone's money. Your better off buying crypto or nfts then giving anything money associated with the Chaaban name at one time or another.
Unless you want to make a donation. Then by all means carry on if that's your sort of a thing.
Bearish All capitals
Chaaban family stocks do nothing. All his old partners or everyone that comes into his orbit calls him a scammer eventually he burns every bridge behind him. Always plays the victim he has nothing going on for anyone not in his family or he can use to validate his usual Grandiose promise's.
All this can be researched you are obviously Bill or one of his friends the ride ends here my friend you left to much of a trail behind you and you have to much baggage of Bahiges own creation to go further.
There is nothing here but the Da Bear's
Wrong people invest in reputations especially in this economy and The Chaabans name is toasted.
You say you have never seen proof of it right and when you say we any newbies will eventually if they research the right way.
This company does not have 50 million in approaching debt! Bill knows this and this is why he ran! All this presto magic is a smoke screen FOLLOW THE S1 the Chaabans and Eloaf and the lawyer who is is going to get his butt disbarred that's all you have to do simple don't listen to anything else.
Set your Google alerts and sec filings to Fitx, Cenbf & Eloaf notifications.
Facts are S1 financial figures are not true. Forty million right He tried to do nothing for shareholders with their money. How about you prove that?
Facts are he even burnt Mosad who is posting his losses on Facebook dealing with Chaaban and his companies and their subsidiaries. Only ones that make out from Bills companies are Chaabans.